跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
找到 6,930 条关于
“muscarinic acetylcholine pathway”
全部
6,930
临床试验
1,795
药物
126
机构
14
资讯
4,995
去年
Major Pipeline Expansion in Schizophrenia Treatment: 55+ Companies Developing 60+ Novel Therapies
9个月前
Schizophrenia Drug Pipeline Surges with 60+ Therapies from 55+ Companies as Novel Mechanisms Enter Late-Stage Development
去年
Neurocrine Biosciences Advances Novel Muscarinic M4 Agonist to Phase 3 Trials for Schizophrenia
去年
FDA Approves Cobenfy, a Novel Muscarinic Receptor-Targeting Drug for Schizophrenia
去年
Zai Lab's KarXT Shows Positive Phase 3 Results for Schizophrenia Treatment in China
3个月前
Cholinergic Regulation of Neuroinflammation: Microglia, Immunometabolism, and Therapeutic Frontiers
去年
Xanomeline/Trospium Chloride (COBENFY™) Approved for Schizophrenia Treatment
去年
Zai Lab's KarXT Receives NMPA Acceptance for Schizophrenia Treatment in China
10个月前
Neumora Therapeutics Initiates Phase 1 Trial for Second M4 Muscarinic Receptor Modulator NMRA-898
去年
Cobenfy Approved for Schizophrenia: A Novel Muscarinic Receptor Agonist
第 1 页，共 500 页
上一页
下一页
